Symbols

GH

Guardant Health·NASDAQ

--(--)

GH Profile

Guardant Health, Inc.

A leading precision oncology company that provides non-invasive cancer testing and analytics

Industry

Biological Technology

Established Date

Listing Date

10/04/2018

Exchange

NASDAQ Stock Exchange

Full-time Employees

2,490

Fiscal Year Ends

12-31

Website

www.guardanthealth.com

Security Type

Common stock

Office address

3100 Hanover Street, Palo Alto, California, 94304

Business

Introduction

Guardant Health, Inc., was incorporated in Delaware in December 2011. The company is a leading precision oncology company dedicated to helping the world conquer cancer through the use of its proprietary blood tests, extensive datasets and advanced analysis. They revolutionize patient care by providing key insights into disease drivers using advanced blood and tissue testing, real-world data, and artificial intelligence analysis. Their tests help improve treatment outcomes at all stages, including early cancer screening, early cancer recurrence monitoring, and treatment option selection for patients with advanced cancer.